TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) › Cash & EquivalentsTEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2006-12-31: $1.33B2007-12-31: $1.49B2008-12-31: $1.85B2009-12-31: $2.00B2010-12-31: $1.25B2011-12-31: $1.10B2012-12-31: $2.88B2013-12-31: $1.04B2017-12-31: $963.00M2018-12-31: $1.78B2019-12-31: $1.98B2020-12-31: $2.18B2021-12-31: $2.17B2022-12-31: $2.80B2023-12-31: $3.23B2024-12-31: $3.30B2025-12-31: $3.56B$3.56B2006-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$3.56B+7.8%2026-02-03Balance as of period end2024-12-31$3.30B+2.3%2026-02-03Balance as of period end2023-12-31$3.23B+15.2%2026-02-03Balance as of period end2022-12-31$2.80B+29.4%2025-02-05Balance as of period end2021-12-31$2.17B-0.6%2024-02-12Balance as of period end2020-12-31$2.18B+10.2%2023-02-10Balance as of period end2019-12-31$1.98B+10.8%2022-02-09Balance as of period end2018-12-31$1.78B+85.0%2020-02-21Balance as of period end2017-12-31$963.00M—2019-02-19Balance as of period end2013-12-31$1.04B-63.9%2014-02-10Balance as of period end2012-12-31$2.88B+162.7%2014-02-10Balance as of period end2011-12-31$1.10B-12.2%2014-02-10Balance as of period end2010-12-31$1.25B-37.4%2014-02-10Balance as of period end2009-12-31$2.00B+7.6%2013-02-12Balance as of period end2008-12-31$1.85B+24.6%2012-02-17Balance as of period end2007-12-31$1.49B+11.7%2011-02-15Balance as of period end2006-12-31$1.33B—2010-02-22Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)